drugset / Trial / NCT04342572
Intra-arterial Chemotherapy for Retinoblastoma
NaSingle-groupOpen-labelTreatment
Summary
Children with retinoblastoma who may benefit from intra-arterial chemotherapy will receive up to 3 doses of melphalan and will be assessed for feasibility, toxicity, and response.
Timeline
- Start
- 2020-08-11
- Primary completion
- 2023-01-04
- Completion
- 2025-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melphalan | Small molecule | — | Other |